Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, September 18, 2018
Thermo Fisher Scientific has licensed CRISPR technologies from the Broad Institute and ERS Genomics (foundational University of California IP) to bolster its genome editing intellectual property (IP) portfolio.
read more
Wednesday, September 19, 2018
The Virginia Department of Criminal Justice Services announced Qlarion has been awarded a contract to construct a data-sharing and analysis platform that will improve Virginia’s response to the opioid crisis.
read more
Wednesday, September 19, 2018
Just Biotherapeutics and Pandion Therapeutics announced they have entered into an agreement for the development and cGMP clinical manufacturing by Just of Pandion’s lead program.
read more
Wednesday, September 19, 2018
Abzena has signed an agreement with Tmunity Therapeutics, a clinical stage T cell therapy company in the development of new Chimeric Antigen Receptor T Cell (CAR-T) therapies.
read more
Wednesday, September 19, 2018
Emmaus Life Sciences has entered into a distribution agreement with Cardinal Health.
read more
Wednesday, September 19, 2018
Legacy Health has selected Trellis Rx, a leading technology-enabled specialty pharmacy service provider, to help Legacy launch a patient-centered specialty pharmacy program.
read more
Thursday, September 20, 2018
SCOUT has formed a joint venture with Rare Expertise, a company with proprietary data-driven tools for identifying and activating people with rare disorders.
read more
Thursday, September 20, 2018
Merrimack Pharmaceuticals has received a $5 million milestone payment from Shire, triggered by the sale of Onivyde in the first major non-European, non-Asian country.
read more
Friday, September 21, 2018
The FDA has issued a warning letter to Pharmaceutical Laboratories and Consultants regarding several violations at the Illinois-based lab, including the presence of a microbrewery in its drug testing area.
read more
Friday, September 21, 2018
The FDA is finalizing two guidance documents and making available one draft guidance to help ensure that prescription drug products are identified and traced properly as they move through the supply chain in compliance with federal law.
read more
Friday, September 21, 2018
Mylan announced the U.S. launch of Dalfampridine Extended-Release Tablets, 10 mg, the authorized generic version of Acorda's Ampyra.
read more
Monday, September 24, 2018
GeneCentric Therapeutics announced that the company has acquired an exclusive license from the UNC at Chapel Hill to technology for subtyping Pancreatic Ductal Adenocarcinoma.
read more
Monday, September 24, 2018
A new cell based profiling service for drug discovery from Reaction Biology Corporation (RBC) and Promega Corporation will allow more researchers to better prioritize compounds earlier.
read more
Monday, September 24, 2018
ABEC announced the shipment of Emergent BioSolutions’ CSR dual purpose single-use systems for large scale 750L microbial fermentation and 500L mammalian cell culture.
read more
Monday, September 24, 2018
Cerveau announced a research collaboration agreement with Ionis for use of [F-18]MK-6240, an investigational imaging agent to be used in PET scans for assessing the status and progression of NFTs in the brain.
read more